The Journal of Drug Assessment is an open-access, online-only, peer-reviewed journal that publishes a variety of study types from a range of therapeutic areas. We welcome smaller and lesser impact studies, results from trials that have not met their end-points, and studies with confirmatory findings from Phase I–Phase IV trials. The journal’s scope — combined with the transparent and rigorous peer review process — will make certain that papers are accepted based on their scientific merit (i.e., technically sound, well-written, comprehensive reports), not on the novelty or impact of the results. In addition, the rapid publication timeline allows for online publication with 5-7 weeks of submission, while always ensuring total transparency of the peer-review process and disclosure of financial and other relevant relationships for all submitted manuscripts.
When you submit to the journal, please use this 20% discount code: IJDA-20-2017. The code will be valid until December 31, 2018.
- Click here to read the journal's instructions for authors page
- Click here to submit to the journal online
- Editor-in-Chief: Dr Dimitri Mikhailidis , Royal Free Hospital, London
- Medical Editor: Kelly Soldavin, Taylor & Francis (Kelly.Soldavin@taylorandfrancis.com)